Jove
Visualize
Contact Us

Related Experiment Videos

Immune response to staphylococcal superantigens.

T Krakauer1

  • 1Department of Immunology and Molecular Biology, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21702-5011, USA.

Immunologic Research
|December 2, 1999
PubMed
Summary

Staphylococcal superantigens, like staphylococcal enterotoxins (SEs) and toxic shock syndrome toxin-1 (TSST-1), trigger severe immune responses and diseases. This review covers their effects, research using knockout mice, and potential therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Staphylococcus aureus: the toxic presence of a pathogen extraordinaire.

Current medicinal chemistry·2009
Same author

The flavonoid baicalin inhibits superantigen-induced inflammatory cytokines and chemokines.

FEBS letters·2001
Same author

Serum cytokine levels and antibody response to influenza vaccine in the elderly.

Immunopharmacology and immunotoxicology·2001
Same author

Suppression of endotoxin- and staphylococcal exotoxin-induced cytokines and chemokines by a phospholipase C inhibitor in human peripheral blood mononuclear cells.

Clinical and diagnostic laboratory immunology·2001
Same author

Pentoxifylline inhibits ICAM-1 expression and chemokine production induced by proinflammatory cytokines in human pulmonary epithelial cells.

Immunopharmacology·2000
Same author

Coordinate suppression of superantigen-induced cytokine production and T-cell proliferation by a small nonpeptidic inhibitor of class II major histocompatibility complex and CD4 interaction.

Antimicrobial agents and chemotherapy·2000
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Immunology
  • Microbiology
  • Toxicology

Background:

  • Staphylococcal exotoxins, including staphylococcal enterotoxins A-E (SEA-SEE) and toxic shock syndrome toxin-1 (TSST-1), are potent immune system activators.
  • These toxins, termed superantigens, induce polyclonal T cell activation at picomolar concentrations by binding MHC class II and T cell receptor Vbeta regions.
  • This interaction leads to excessive proinflammatory cytokine production and T cell proliferation, causing symptoms like fever, hypotension, and shock.

Purpose of the Study:

  • To summarize the in vitro and in vivo effects of staphylococcal enterotoxins and TSST-1.
  • To review recent advancements in using transgenic knockout mice to identify key mediators and receptors in superantigen-induced shock.
  • To discuss therapeutic agents for mitigating the toxic effects of staphylococcal superantigens.

Related Experiment Videos

Main Methods:

  • Review of in vitro and in vivo studies on staphylococcal enterotoxins and TSST-1.
  • Analysis of research utilizing transgenic knockout mice to investigate superantigen mechanisms.
  • Examination of therapeutic strategies targeting staphylococcal superantigens.

Main Results:

  • Staphylococcal superantigens cause significant immune activation, cytokine release, and T cell proliferation.
  • Transgenic knockout mouse models have helped identify critical mediators and receptors in superantigen-induced shock.
  • Emerging therapeutic agents show promise in mitigating the adverse effects of these toxins.

Conclusions:

  • Staphylococcal superantigens are critical virulence factors responsible for various diseases, including food poisoning and toxic shock.
  • Understanding the molecular interactions and host responses is crucial for developing effective treatments.
  • Further research into therapeutic interventions is essential to combat the severe health consequences of staphylococcal superantigen exposure.